Overview

STA-21 Topical Efficacy on Psoriasis

Status:
Completed

Trial end date:
2008-04-01

Target enrollment:

Participant gender:

Summary

The clinical assessment of patients with plaque-type psoriasis is performed by open, intrapatient comparison of 0.2% STA-21 with vehicle(Vaseline) alone within a 2 week period.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Kochi University